Aquavit Files Investigational New Drug Application for its Flagship Intradermal Injection of Botulinum Toxin ...Middle East

NEW YORK, April 28, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin applications, announced today that it has filed an Investigational New Drug Application with the FDA for its flagship intradermal injection of...

Hence then, the article about aquavit files investigational new drug application for its flagship intradermal injection of botulinum toxin was published today ( Friday 28/04/2023 - 08:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aquavit Files Investigational New Drug Application for its Flagship Intradermal Injection of Botulinum Toxin )

Also on site :

• Stunning ISS Photo of Florida, Cuba Captures & 039;Moonglint& 039;
• A Shockingly Recent Year Just Cracked the Top 5 of Rock's Most Legendary Years
• Saudi-led coalition strikes Yemeni port over unauthorised weapons shipment